LIN vs OSG · P/E 34, rev $18.07B vs rev $187.2M
Linde plc Ordinary Shares (LIN) versus Octave Specialty Group, Inc. (OSG) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Octave Specialty Group, Inc. (OSG) is a insurance - specialty company listed on NYSE.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported OSG revenue for 2026-06-30 was $187.2M. Net income was -$15.0M. Revenue was up 79.7% from 2026-03-31 to 2026-06-30. OSG currently screens at market cap $260.2M.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. OSG currently screens at market cap $260.2M.
Not investment advice. Open the LIN and OSG stock pages for the full models.
Not investment advice.